Cardiovascular Stent Articles & Analysis
4 news found
ArterioSorb™ is a next-generation bioresorbable cardiovascular scaffold (BRS, stent), to be implanted within the coronary arteries in order to open blocked vessels, and to biodegrade within two years when healing is complete and it is no longer needed. ...
Arterius Limited, a Leeds-based, UK company developing innovative medical devices with a focus on next generation bioresorbable coronary and peripheral stents, has announced that it has appointed Steve Parker as Chief Executive Officer. ...
A great asset in different clinical specialties "We immediately saw the potential in this partnership," adds Thomas Walter, vice president of Vygon's Intravascular Therapy (IVT) and Cardiovascular & Surgery (CVS) Business Unit. "Our customers have tested Digital SedationTM in some of their minimally invasive cardiovascular procedures (angioplasty, ...
Abbott acquired his firm, carotid stent specialist MedNova, in 2005. At the time, it was one of Ireland's biggest med tech success stories. Today, Taylor is on the verge of commercialising his new venture, Veryan Medical, which is another cardiovascular device company that makes innovative stent treatments for the lesions that block blood flow ...